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ABSTRACT The aim of this study was to investigate the
effect of medium-chain triacylglycerol (MCT) ingestion during
exercise on subsequent time-trial cycling performance. Seven
well-trained cyclists performed four exercise trials consisting of
2 h at 60% of maximal oxygen uptake followed by a simulated
time trial (ie, completion of a preset amount of work as fast as
possible) of <15 min duration. During the trials, subjects ingest-
ed 1) a 10% carbohydrate solution (CHO; 170 ± 6 g glucose), 2)
a 10% carbohydrate electrolyte with 5% MCT solution (CHO +
MCT; 85 ± 3 g MCT), 3) a 5% MCT solution, or 4) artificially
colored and flavored water (placebo). Neither CHO nor CHO +
MCT ingestion had any effect on performance compared with
placebo ingestion, whereas ingestion of MCT had a negative
effect on performance. Average work rates during the time trial
were 314 ± 19, 314 ± 13, and 312 ± 18 with CHO, CHO + MCT,
and placebo, respectively, and was 17–18% lower in the MCT
trial (263 ± 22 W). In addition, compared with placebo ingestion,
MCT ingestion had no effect on total rates of fat or carbohydrate
oxidation, nor did it affect exogenous or endogenous carbohy-
drate utilization. The negative effect of MCT ingestion was asso-
ciated with increased gastrointestinal complaints (ie, intestinal
cramping). These data suggest that large amounts of MCTs (85
g) ingested during prolonged submaximal exercise may provoke
gastrointestinal problems leading to decreased exercise perfor-
mance. Am J Clin Nutr 1998;67:397–404.
KEY WORDS Medium-chain triacylglycerol, exercise,
maximal oxygen uptake, substrate utilization, carbohydrate, men
INTRODUCTION
Carbohydrate supplementation has received much attention in
exercise physiology since the late 1960s. Carbohydrate feedings
have been shown to increase performance during prolonged
exercise lasting ‡ 1 h (1–3). Ingested carbohydrates may be oxi-
dized at rates of up to 1 g/min, the apparent maximal oxidation
rate of this exogenous substrate (4, 5). Therefore, we argued that
medium-chain triacylglycerols (MCTs) may be a valuable addi-
tional substrate to be ingested during exercise (6–8). MCTs have
a smaller molecular size, a lower melting point, and are more
soluble in water than are long-chain triacylglycerols. Because of
these physical properties, MCTs are rapidly absorbed and enter
the liver directly through the portal vein, whereas long-chain tri-
acylglycerols have to be transported through the relatively slow
lymphatic system (9). Studies with stable isotopes have shown
that medium-chain fatty acids are rapidly oxidized when the
body is at rest (10) and during exercise (7, 11). We showed that
carbohydrates coingested with MCTs accelerated the oxidation
of MCTs during the first 90 min of exercise (7). By adding
MCTs to a carbohydrate solution, the oxidation rates of these
carbohydrates will not be impaired (8), and the MCTs can serve
as additional fuel for the working muscle (6, 7). However, in
recent studies we found that MCTs, although rapidly oxidized,
contributed only marginally to total energy expenditure (6, 7)
and did not spare muscle glycogen (8). In these studies, the
amount of MCTs ingested was small (<30 g) and no rise in
plasma fatty acids was observed after ingestion.
Studies in which high plasma fatty acid concentrations were
induced by giving either a high-fat meal or an intravenous infusion
of a triacylglycerol emulsion (Intralipid; Kabi Pharmacia, Woer-
den, Netherlands) in combination with heparin reported reduced
muscle glycogen utilization during exercise compared with con-
trol conditions (12–14). This led to the suggestion that ingestion
of sufficient amounts of MCTs may elevate plasma fatty acid con-
centrations, spare muscle glycogen, and improve performance.
Van Zeyl et al (15) gave subjects large amounts of MCTs (86 g)
during 2 h of cycling exercise at 60% of maximal oxygen uptake
(V·CO2max) followed by a 40-km time trial. Unfortunately, the
study had no water control group (without carbohydrate and MCT
ingestion), so the separate effect of MCTs on performance could
not be studied. We previously observed gastrointestinal discomfort
in subjects who ingested MCTs in large quantities, which, of
course, may have negatively affected performance.
Accordingly, the aim of this study was to examine the meta-
bolic effects of ingesting a large quantity of MCTs (85 g) both
alone and in combination with carbohydrates compared with the
effects of carbohydrate or water ingestion during 2 h of cycling.
A second purpose was to investigate the effect of the ingestion of
carbohydrates, MCTs, carbohydrates plus MCTs, or water on
subsequent time-trial cycling performance.
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SUBJECTS AND METHODS
Subjects
Seven endurance-trained male cyclists who regularly trained >
2 h/d, 4–7 d/wk, were recruited for this study. Five to seven days
before the first experimental trial, V·O2max, maximal work rate
(Wmax), and peak heart rate (HRpeak) were determined in a
stepwise incremental exercise test to exhaustion as described by
Kuipers et al (16).
Maximal work test
After a warm-up period of 5 min at 100 W, the work rate was
increased by 50 W every 2.5 min until a heart rate of 160
beats/min was reached. Then the work rate was increased by 25
W every 2.5 min. The Wmax (in W) was determined by the fol-
lowing equation:
Wmax = Wout + (t/150 s) 3 25 Watts (1)
where Wout (in W) is the last completed stage and t is the time
(in s) in the final stage. All exercise tests were performed on an
Excalibur Sport electromagnetically braked cycle ergometer
(Lode, Groningen, Netherlands). Heart rate was measured con-
tinuously by a Polar Vantage heart rate monitor (Polar, Kelmele,
Finland). Mean – SEM V·O2max, Wmax, and HRpeak were 74 –
1 mL · kg21 · min21, 401 – 17 W, and 187 – 1 beats/min, respec-
tively. The study was approved by the Maastricht University and
Academic Hospital Maastricht Medical Ethical Committee,.
Procedure
On the day of the test, subjects reported to the laboratory at
1200 after consuming a standardized breakfast in the morning.
At the laboratory a standardized lunch was provided. At 1315, a
polytetrafluoroethylene catheter (Baxter Quick Cath; Utrecht,
Netherlands) was inserted into an antecubital vein and connected
to a three-way stopcock (Discofix-3; Braun, Meisungen, Ger-
many). At 1330, a resting blood sample was drawn. Resting
breath gases were collected for the measurement of oxygen con-
sumption and carbon dioxide production (Oxycon b, Mijnhard,
Netherlands). At 1355, subjects cycled for 5 min at 100 W as a
warm-up. At 1400, subjects started cycling at 60% V·O2max for 
2 h, and in the first minute they had to drink an initial bolus 
(8 mL/kg) of one of the test drinks. Thereafter, every 15 min a
beverage volume of 2 mL/kg was provided. Blood samples (10
mL) were collected every 30 min and expiratory gases were col-
lected every 15 min in 15-mL evacuated tubes (Becton Dickin-
son and Co, Orangeburg, NY).
Time trial
After 120 min of exercise at 60% V·O2max, a simulated time
trial of <15 min duration was performed as described previously
(17). Subjects were asked to perform a certain amount of work
(equal to <15 min cycling at 75% of their maximal work load)
as fast as possible. The measurement of performance was the
time to complete the set amount of work. This total amount of
work was based on Wmax and was calculated as follows:
Total amount of work = 0.75 3 Wmax 3 900 s (2)
For this trial, the ergometer was set in the pedaling rate depen-
dent mode. In this mode, power varies with RPM according to
the following formula:
W = L 3 (RPM)2 (3)
in which W is the work rate (in W), RPM is the pedaling rate,
and L is a coefficient (W/RPM2) that is dependent on the subject’s
Wmax. L was chosen in such a way that, at a pedaling rate of 90
RPM, 70% Wmax was elicited. Thus, the coefficient L was calcu-
lated by solving equation 3 for L in terms of Wmax and pedaling
rate (ie, L = 0.70 Wmax / (90 RPM)2 = 0.70 Wmax/8100 = 8.64 3
1025 Wmax). The ergometer was connected to a computer (Apple
Macintosh Powerbook 5300cs; software developed by L Wouters
and A Jeukendrup) that recorded work rate and time on-line and
calculated the amount of work performed as previously described
(17). The only information the subjects received was the amount
of work performed and the percentage of work performed relative
to the preset amount of work (0% at the start and 100% at the end
of the trial). Subjects did not receive information regarding work
rate, pedaling rate, time, or heart rate. During all tests, environ-
mental conditions were standardized, temperature was kept at 
20°C, and an electric fan circulated air to minimize thermal stress.
Subjects were encouraged by the same person in every test. This
performance test has been shown to produce highly reproducible
results: the CV of this test was 3.35% (17).
To avoid any influence of circadian variance, subjects always
performed their tests at the same time of day. Subjects were not
allowed to train on the day before the test. Two days before the
test, training was not allowed to be exhaustive. Additionally, all
subjects were instructed to eat the same evening meal, which was
controlled by a registration procedure, before the test and were
advised to eat a carbohydrate-rich meal such as pasta. So that we
could further control carbohydrate and energy intake, subjects
provided food records for the day before the test and for the day
of the test.
Beverages
Subjects received four drinks on four different occasions, sub-
sequent tests being separated by ‡ 5 d. The drinks consumed
were 1) a 10% carbohydrate solution (CHO; 170 ± 6 g glucose),
2) a 10% carbohydrate solution with 5% MCTs (CHO + MCT;
170 ± 6 g glucose, 85 ± 3 g MCTs), 3) a 5% MCT solution (85
± 3 g MCTs), or 4) a placebo consisting of artificially colored
and flavored water. The carbohydrates in the CHO + MCT and
CHO drinks consisted of corn-derived glucose (Amylum; Aalst,
Belgium) and the 13C enrichment of these carbohydrates was
211.3 d per mil versus Pee Dee Bellemnitella (PDB) standard as
determined by combustion isotope-ratio mass spectrometry
(Carlo Erba–Finnigan MAT 252; Bremen, Germany). Ninety-
nine percent of the fatty acids in the MCT had a chain length of
eight carbons (Trioctanoate, Estasan GT8-99; Unichema,
Barcelona, Spain). To each 1L of drink 5 g fructose, 730 mg cit-
ric acid, 160 mg aspartame, and 640 mg of a flavor substance
(orange) were added to make the taste comparable in all trials.
Subjects ingested 8 mL/kg of one of the drinks during the first
minute of the warm-up period and 2 mL/kg every 15 min there-
after. Such a drinking pattern was reported previously to result in
high rates of gastric emptying throughout exercise (18). Drinks
were given in a randomized order and subjects were unaware of
the content of the drink.
During the CHO and CHO + MCT trials, subjects ingested a
glucose solution with a high natural abundance of 13C so that oral
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glucose oxidation could be studied. The placebo trial was used to
allow for correction for changes in breath 13CO2 background
enrichment during exercise. To avoid background shifts, standard
procedures were followed (5–7, 19). Subjects were instructed not
to consume any products with a high natural abundance of 13C dur-
ing the entire experimental period. This was done to minimize a
shift in background enrichment due to changes in endogenous sub-
strate utilization. Furthermore, subjects were instructed to keep
their diets as constant as possible on the days before the trials.
Analysis
Blood (5 mL) was collected into EDTA-containing tubes and
centrifuged at 1500 3 g at 4 °C for 4 min. Aliquots of plasma were
frozen immediately in liquid nitrogen and stored at 240 °C until
concentrations of glucose (Uni Kit III, 0710970; Hoffman-La
Roche, Basel, Switzerland), lactate (20), ß-hydroxybutyrate (21),
fatty acids (Wako FFA-C test kit; Wako Chemicals, Neuss, Ger-
many), and glycerol (GPO-trinder 337; Sigma Diagnostics, St
Louis) were analyzed, with use of the COBAS BIO semi automatic
analyzer (Hoffman-La Roche). From indirect calorimetry (respira-
tory quotient and V·O2) and stable isotope measurements
(13CO2/12CO2; continuous flow IRMS; Finnigan MAT 252, Bremen,
Germany), total energy expenditure and oxidation rates of total fat,
total carbohydrates, and exogenous glucose were calculated.
Calculations
From carbon dioxide production (V·CO2) and V·O2, carbohy-
drate and fat oxidation rates were calculated by using stoichio-
metric equations (22).
Glucose oxidation = 4.585 V·CO2 2 3.226 V·O2 (4)
Fat oxidation = 1.695 V·O2 2 1.701 V·CO2 (5)
The isotopic enrichment was expressed as the d per mil dif-
ference between the 13C and 12C ratios of the sample and a
known laboratory reference standard according to the formula of
Craig (23):
d13C per mil = [( 13C/12C sample 2 1)] 3 103 (6)13C/12C standard
The d 13C was then related to the international standard Pee
Dee Bellemnitella (PDB-1).
The amount of glucose oxidized was calculated according to
the formula:
Exogenous glucose oxidation = V·CO2 3 (dExp 2 dbkg)(1) (7)dIng 2 dbkg k
in which dbkg is the 13C enrichment of expired air in the back-
ground trial (the placebo served as the background correction
trial), dExp is the 13C enrichment of expired air during exercise
at different time points, dIng is the 13C enrichment of the
ingested glucose, and k is the amount of CO2 (in L) produced by
the oxidation of 1 g glucose (k = 0.7467 L CO2/g glucose).
Endogenous glycogen utilization was calculated as follows:
Endogenous glycogen utilization = 
total carbohydrate oxidation 2
exogenous glucose oxidation (8)
Questionnaires
At 0, 60, and 120 min, and at the completion of the time trial,
subjects were asked to fill out a questionnaire. This question-
naire contained questions about the presence of gastrointestinal
discomfort or problems at that moment. Specifically, these ques-
tions addressed possible complaints of nausea, bloated feeling,
belching, gastrointestinal cramping, vomiting, diarrhea, urge to
defecate, headache, and dizziness. These items were scored on a
10-point scale.
Statistics
Data were analyzed by using a two-way analysis of variance
(ANOVA) with repeated measures (treatment 3 time). In cases
of statistical significance, differences were located with a
Scheffe post hoc test. Although trials were counterbalanced in
this study, we checked the possible test-order effect on exercise
performance (the first trial compared with the second, compared
with the third, and compared with the fourth) by using a one-way
ANOVA with repeated measures with the test order as the factor.
The level of significance was set at P < 0.05. All results are pre-
sented as means ± SEM.
RESULTS
Time-trial cycling performance
Times to complete the preset amount of work in the four trials
are presented in Table 1 and were not significantly different
among the CHO, CHO + MCT, and placebo trials. The time to
accomplish the preset amount of work in the MCT trial was sig-
nificantly longer than in the other trials. There was no effect of
test order. Average work rate during the time trial was 17–18%
lower in the MCT trial than in the other trials (Table 1). The
mean heart rate was also significantly lower during the MCT
trial than in the other trials, in which the mean heart rates were
comparable. No statistical differences were observed in peak
heart rate during the time trial or in ratings of perceived exertion.
Blood indexes
During the 120 min of steady state exercise, plasma glucose
concentrations initially rose from resting values of 4.6–5.1
mmol/L to 5.8 mmol/L during the CHO and CHO + MCT trials,
whereas in both the placebo and MCT trials plasma glucose con-
centrations tended to decline (Figure 1). Plasma glucose con-
centrations during the MCT trials (and the placebo trial at 60
min) were significantly (P < 0.05) lower during the 2 h of exer-
cise than were the concentrations during the two CHO trials
(CHO and CHO + MCT). Plasma glucose concentrations
increased during the time trial but this increase was significant
only in the MCT and placebo trials (Figure 1).
Plasma lactate concentrations during the 120 min of exercise
were stable and similar in all trials, and average values were < 1
mmol/L (0.7–0.9 mmol/L; Figure 1). Plasma lactate increased
during the time trial to high concentrations during the CHO,
CHO + MCT, and placebo trials (8.0–10.3 mmol/L) and
increased less during the MCT trials (3.6 mmol/L; Figure 1).
Plasma fatty acid concentrations increased from resting values
of between 213 and 292 mmol/L to 406 ± 87 mmol/L during
CHO trials, to 506 ± 87 mmol/L during the CHO + MCT trials,
and to values > 700 mmol/L at the end of 2 h of exercise when
no carbohydrates were ingested (722 ± 146 mmol/L during the
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placebo trials and 820 ± 134 mmol/L during the MCT trials).
During exercise, plasma fatty acid concentrations were signifi-
cantly higher (P < 0.05) during the MCT trials than during the
CHO or CHO + MCT trials (except at 120 min). Also, during the
time trial plasma fatty acids were higher in the MCT trial than in
the other trials (Figure 1).
Glycerol concentrations rose gradually during exercise in all
trials. Although glycerol concentrations seemed to be somewhat
lower by the end of 2 h of exercise in the CHO trials, this differ-
ence was not statistically significant. Only at 120 min were glyc-
erol concentrations during the placebo trials significantly (P <
0.05) higher than during the CHO or CHO + MCT trials. During
the time trials, glycerol concentrations further increased and
concentrations remained lower in the CHO feeding trials (P<
0.05; Figure 1).
b-Hydroxybutyrate concentrations showed a small rise from
200–250 to 222–380 mmol/L during the CHO, CHO + MCT, and
placebo trials but increased markedly during the MCT trials (to
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TABLE 1
Time trial results: time to complete the preset amount of work, mean heart rate (HR), peak HR, and ratings of perceived exertion (RPE) during the time trial1
Trial Duration Average work rate Mean HR Max HR RPE2
min W bpm bpm
CHO 14.18 ± 0.57 314.4 ± 18.5 180 ± 2 187 ± 2 9.14 ± 0.34
CHO + MCT 14.02 ± 0.32 313.9 ± 13.0 181 ± 2 187 ± 2 9.29 ± 0.29
MCT 17.33 ± 1.103 263.1 ± 22.43 170 ± 43 182 ± 6 9.00 ± 0.44
PLAC 14.43 ± 0.70 311.6 ± 17.8 182 ± 2 187 ± 2 8.57 ± 0.81
1 x– ± SEM; n = 7. bpm, beats per minute; CHO, glucose solution; CHO + MCT, glucose and medium-chain triacylglycerol solution; MCT, medium-
chain triacylglycerol solution; PLAC, artificially colored and flavored water solution.
2 Scored from 1 to 10.
3 Significantly different from the other trials, P < 0.05.
FIGURE 1. Plasma glucose, lactate, fatty acids, glycerol, and b-hydroxybutyrate during 120 min of exercise at 60% of maximal oxygen uptake
(V·O2max) followed by a time trial (<15 min) with ingestion of a 10% carbohydrate solution (CHO), a 10% carbohydrate solution with 5% medium-
chain triacylglycerols (CHO + MCT), a 5% MCT solution (MCT), or a placebo consisting of artificially colored and flavored water (PLAC). x– ± SEM;
n = 7. Means with different superscript letters are significantly different (P < 0.05) as follows: a, significant difference between CHO and MCT; b, sig-
nificant difference between CHO + MCT and MCT; c, significant difference between CHO and placebo; d, significant difference between CHO + MCT
and placebo; e, significant difference between MCT and placebo; and f, significant difference between CHO and CHO + MCT.
883 mmol/L; P< 0.05). During the time trial, b-hydroxybutyrate
concentrations also significantly increased (to 1.1–1.7 mmol/L;
Figure 1).
Indirect calorimetry
During the second hour of exercise, R values averaged
0.88–0.91 in the CHO and CHO + MCT trials and were signifi-
cantly lower in the MCT and placebo (0.83–0.88) trials. Carbo-
hydrate ingestion reduced fat oxidation in both the CHO and
CHO + MCT trials compared with the placebo and MCT trials
and maintained carbohydrate oxidation rates of > 2 g/min (Fig-
ure 2). Without carbohydrate ingestion, carbohydrate oxidation
rates decreased to 1.5 g/min (Figure 2). No differences in carbo-
hydrate or fat oxidation were observed between the CHO and
CHO + MCT trials or between the placebo and MCT trials.
Exogenous glucose oxidation
Background 13C enrichment measured from the resting breath
samples was 226.1 ± 0.2 d per mil versus PDB-1. With inges-
tion of the corn-derived glucose in the CHO and CHO + MCT
trial, the rise in 13C was significant, reaching a d per mil versus
PDB-1 difference of <3.5 toward the end of 120 min of exercise
(compared with resting breath sample). The changes in back-
ground enrichment during exercise in the placebo trial were
<10% of the 13C enrichment provoked by the exogenous glucose
in the CHO and CHO + MCT trials. Therefore, a background
correction was made for the calculation of exogenous glucose
oxidation, by using the data from the placebo trial. No differ-
ences were observed in background enrichment between MCT
and placebo. Exogenous glucose oxidation showed a gradual
increase over time and leveled off after <75 min (Figure 3).
Maximal oxidation rates were 0.81 ± 0.03 g/min in the CHO
trials and 0.78 ± 0.03 g/min in the CHO + MCT trials. No dif-
ferences in oral carbohydrate oxidation between the CHO and
CHO + MCT trials were observed. Endogenous carbohydrate
(liver and muscle glycogen) oxidation rates as calculated from
total carbohydrate oxidation minus exogenous glucose oxidation
were similar in the CHO and CHO + MCT trials (Figure 3).
Gastrointestinal discomfort
Gastrointestinal complaints were registered by means of a
questionnaire. Selected complaints are displayed in Table 2.
Vomiting and diarrhea were not reported during exercise. Two
subjects vomited after the MCT trial and three complained of
diarrhea afterward. Nausea, headache, and dizziness were not
significantly different among the trials. Belching and a bloated
feeling in the stomach were more often reported when the CHO,
CHO + MCT, or MCT beverage was ingested compared with the
placebo. Gastrointestinal cramps occurred significantly more
often when the MCT beverage was ingested, and this was the
most serious complaint reported during exercise.
DISCUSSION
Fat supplementation during exercise is believed to be undesir-
able for several reasons. First, endogenous fat stores are very
large and therefore fat ingested during exercise would not add
appreciable triacylglycerol to the total body content. Second, the
digestion and absorption of fat is slow and the appearance of
ingested long-chain triacylglycerols in the bloodstream may take
3–4 h. Dietary fat contains long-chain triacylglycerols that, after
being hydrolyzed first in the intestine, diffuse as long-chain fatty
acids into the intestinal mucosa cells for reesterification to tria-
cylglycerols. These long-chain triacylglycerols are then incorpo-
rated into chylomicrons and are transported through the lym-
phatic system, which ultimately drains them into the systemic
circulation. Third, fat will reach the circulation in chylomicrons,
which are generally believed to not be a major energy source for
the working muscle. Aside from this, long-chain triacylglycerols
are known to be potent inhibitors of gastric emptying. For these
reasons, fat supplementation during exercise is not recom-
mended.
The effects of MCTs, however, differ from those of long-chain
triacylglycerols. It has been shown that MCTs do not slow gas-
tric emptying (24), are rapidly hydrolyzed and absorbed, and
enter the systemic circulation directly through the portal vein
(9). It has also been shown that ingested MCTs are oxidized at
high rates relative to their rate of ingestion (6, 7, 11, 25). In addi-
tion to this, we recently showed that MCTs coingested with car-
bohydrates were more rapidly oxidized (ie, they reached maxi-
mal MCT oxidation rates more quickly) than were MCTs alone
(7). Furthermore, we showed that 30 g MCT coingested with car-
bohydrates did not significantly affect exogenous carbohydrate
oxidation during 3 h of exercise at <60% V·O2max (8).
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FIGURE 2. Total carbohydrate and fat oxidation during 120 min of
exercise at 60% of maximal oxygen uptake (V·O2max) with ingestion of
a 10% carbohydrate solution (CHO), a 10% carbohydrate solution with
5% medium-chain triacylglycerols (CHO + MCT), a 5% MCT solution
(MCT), or a placebo consisting of artificially colored and flavored water
(PLAC). x– ± SEM; n = 7. Means with different superscript letters are sig-
nificantly different (P < 0.05) as follows: a significant difference
between CHO and MCT; b, significant difference between CHO + MCT
and MCT; c, significant difference between CHO and placebo; and d,
significant difference between CHO + MCT and placebo.
Only a few studies have investigated the effect of MCT inges-
tion on exercise performance. Satabin et al (26) studied the effect
of MCTs ingested before exercise on exercise capacity and found
no effect of a single 45-g bolus of MCTs or an equienergetic
amount of glucose on time to fatigue at 60% V·O2max. Recently,
van Zeyl et al (15) reasoned that the amount of MCTs provided
was too small to detect performance effects of MCT ingestion
and they gave their subjects 86 g of an MCT solution in repeated
small boluses during exercise. After 120 min of submaximal
exercise at 60% V·O2max, their subjects performed a simulated
40-km time trial. Performance decreased with MCT ingestion
compared with carbohydrate ingestion, but simultaneous inges-
tion of carbohydrates and MCTs resulted in increased perfor-
mance compared with ingestion of carbohydrates alone (ie, aver-
age speed during the time trial). One of these investigators’
hypotheses was that ingestion of carbohydrates in conjunction
with MCTs improved performance compared with ingestion of
carbohydrates alone because of an increased availability of
plasma fatty acids and a subsequent sparing of muscle glycogen
(15). Such effects have been suggested to favorably influence
exercise capacity (27, 28). However, the study by van Zeyl et al
(15) included no placebo control group; therefore, the separate
effect of MCTs compared with control conditions was not inves-
tigated. Thus, the present study was aimed at investigating the
effect on time-trial cycling performance of ingestion of large
amounts of MCTs (85 g) with or without carbohydrates com-
pared with the ingestion of carbohydrates alone or a placebo. As
in the study of van Zeyl et al (15), drinks were ingested during 
2 h of submaximal exercise at 60% V·O2 max and thereafter a
time trial was performed. Interestingly, we found no differences
in performance when subjects ingested CHO, CHO + MCT, or
placebo. However, when subjects ingested MCTs, performance
was significantly decreased.
One of the possible explanations for the fact that in this study
MCTs added to a glucose solution did not have the positive
effect reported by van Zeyl et al (15) is the difference in the
duration of the time trial. We used a 15-min time trial in contrast
with the 60-min time trial used by van Zeyl et al (15); we chose
this duration after pilot studies showed that subjects developed
serious gastrointestinal discomfort when the time trial lasted
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FIGURE 3. Exogenous carbohydrate oxidation during 120 min of exercise at 60% of maximal oxygen uptake (V·O2max) with ingestion of a 10%
carbohydrate solution (CHO) and a 10% carbohydrate solution with 5% medium-chain triacylglycerols (CHO + MCT) and endogenous carbohydrate
oxidation with ingestion of CHO, CHO + MCT, MCT (5% MCT solution), or PLAC (placebo consisting of artificially colored and flavored water). 
x– ± SEM; n = 7.
TABLE 2
Gastrointestinal (GI) discomfort after 120 min of exercise at 60% V·O2max (ie, the start of the time trial) and directly after the time trial1
Headache,
Bloated dizziness, Gastrointestinal
Beverage Nausea Belching feeling or both cramping
CHO 1.0 ± 1.0 1.4 ± 1.02 1.4 ± 1.42 0.7 ± 0.7 0.0 ± 0.0
1.0 ± 1.0 0.0 ± 0.0 1.4 ± 1.42 1.0 ± 0.1 0.0 ± 0.0
CHO + MCT 1.3 ± 1.2 1.2 ± 0.72 2.5 ± 1.52 1.5 ± 0.9 2.0 ± 1.32,3
1.2 ± 1.1 0.3 ± 0.32 1.7 ± 1.12 1.3 ± 1.2 1.8 ± 1.22,3
MCT 0.1 ± 0.1 1.7 ± 0.72 1.7 ± 1.12 1.5 ± 0.9 2.0 ± 1.02,3
1.1 ± 1.1 1.7 ± 0.82 1.1 ± 1.12 1.1 ± 1.1 4.1 ± 1.32,3
PLAC 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.6 ± 0.4 0.0 ± 0.0
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
1 Values are average scores on a questionnaire given at completion of the time trial, in which on a 10-point scale 1 was “no complaints” and 10 was
“very serious complaints.” x– ± SEM; n = 7. CHO, glucose solution; CHO + MCT, glucose and medium-chain triacylglycerol solution; MCT, medium-
chain triacylglycerol solution; PLAC, artificially colored and flavored water solution.
2 Significantly different from PLAC, P < 0.05.
3 Significantly different from CHO, P < 0.05.
longer than 15 min. However, the test-to-test CV of a time trial
lasting <1 h was similar to the CV of a 15-min time trial (17).
Both performance tests have been shown to be highly repro-
ducible (17).
Other differences between the study by van Zeyl et al (15) and
ours may include the type of carbohydrate used (short-chain glu-
cose polymers rather than glucose), the type of MCT used (a
mixture of C8 and C10 rather than pure C8), and the time of the
day at which experiments were performed (morning rather than
early afternoon). How these differences would explain the dif-
ferent findings, however, is unclear.
The most likely explanation for the differences between the
study by van Zeyl et al (15) and the present study may be the dif-
ferences in gastrointestinal discomfort. In this study, subjects
more often reported gastrointestinal cramping during the MCT
trials, which was negatively correlated to their performance.
Because of this gastrointestinal discomfort, subjects reported
that they could not push as hard as they could without gastroin-
testinal discomfort. This is supported by a lower mean heart rate
(Table 1) and lower plasma lactate and b-hydroxybutyrate con-
centrations (Figure 1) during the MCT trials, which are the
results of a lower absolute work rate (Table 1). Similar gastroin-
testinal complaints were reported by Ivy et al (29). The placebo
drinks provoked the least gastrointestinal discomfort, whereas
the CHO drinks, given in these relatively large quantities (on
average 85 g/h), resulted in a bloated feeling. This may be the
explanation for the lack of performance effect after ingestion of
CHO drinks. Van Zeyl et al (15) however, did not report major
gastrointestinal problems during exercise when carbohydrates
and MCTs were ingested.
Interestingly, we did not observe a positive effect on time-trial
performance of carbohydrates compared with placebos. Previ-
ously, we showed that carbohydrate ingestion during exercise
may improve time trial performance lasting <1 h (3). Here the
time trial was relatively short (14 min), which may have pre-
vented a performance effect. However, we strongly feel that the
bloated feeling as reported by the subjects after CHO ingestion
was the major reason for the lack of time-trial performance
improvement. The amount of carbohydrates provided was 75 g/h
in the previous trials for 1-h trials (3), whereas it was 170 g/2 h
in the present study for a 2-h trial. This larger total amount of
carbohydrates ingested may be responsible for the bloated feel-
ing reported by the subjects and the lack of a performance effect
compared with the placebo. However, other factors, such as the
short duration of the performance trial or the small number of
subjects (n = 6) may also have played a role in the lack of a sig-
nificant performance effect of carbohydrates compared with the
placebo.
In the present study, the exercise intensity increased drastically
during the time trial compared with the 120 min of submaximal
exercise at 60% V·O2max. Glycolysis was stimulated and lactate
was formed and accumulated in plasma (Figure 1). Plasma glu-
cose concentrations increased (significantly so in the MCT and
placebo trials) as a result of the high exercise intensity. This was
shown before and was attributed to increased circulating plasma
epinephrine concentrations, which increase hepatic glucose pro-
duction (30). Apparently, the availability of acetyl-CoA units in
the liver increased more than the utilization that caused the large
increase in plasma b-hydroxybutyrate concentration. Responses
seemed to be somewhat less pronounced in the MCT trial, in
which the absolute work rate was somewhat less.
As reported previously (1, 7, 31), carbohydrate ingestion
markedly blunted plasma fatty acid and total fat oxidation and
maintained high rates of carbohydrate oxidation. Although the
amount of MCTs ingested was threefold higher than in previous
studies from our lab (6–8) and by others (11, 25, 29), in agree-
ment with these studies, we found no significant differences in
total fat or carbohydrate utilization with or without MCT inges-
tion (Figure 2). Although statistically not significant, however,
fat oxidation seemed to be slightly higher with ingestion of car-
bohydrates in combination with MCTs than with ingestion of
carbohydrates alone. Because we did not measure exogenous
MCT oxidation or plasma medium-chain fatty acid concentra-
tions in this study, it cannot be determined whether this higher
fat oxidation is the result of MCT oxidation or a reduced sup-
pression of endogenous fat oxidation induced by the ingested
carbohydrates.
Increases in plasma fatty acids and glycerol were blunted by
carbohydrate ingestion, but MCT ingestion had no effect on
plasma fatty acid or glycerol concentrations. We reported before
that glycerol concentrations were not significantly elevated after
MCT ingestion and we suggested that this was due to the capac-
ity of the liver to use glycerol for gluconeogenesis (7).
Also, in agreement with previous findings (8), MCTs did not
influence exogenous or endogenous carbohydrate oxidation
rates. It has been suggested that MCT ingestion may elevate the
plasma fatty acid concentration and subsequently spare muscle
glycogen (12–14). However, several studies have shown that
ingestion of 25–30 g MCTs did not lower the rate of muscle
glycogen breakdown (8, 25, 32, 33). Recently, van Zeyl et al (15)
suggested that the amount of MCTs in the above mentioned stud-
ies was too small to affect muscle glycogen breakdown. There-
fore, they gave their subjects large amounts of MCTs; tracer data
suggested that glycogen breakdown was reduced. However,
these data need to be interpreted with caution. MCT feeding ele-
vated plasma ketone concentrations to high levels and it is
known that ketogenesis may fixate oxygen in the production of
b-hydroxybutyrate. Because the estimates of glycogen break-
down are dependent on V·CO2 and V
·CO2, this may have decreased
the calculated carbohydrate oxidation rates in the MCT trial.
Although we did not measure muscle glycogen concentra-
tions, tracer methods did not show a sparing of endogenous car-
bohydrate stores (in the liver and in muscle glycogen) after MCT
ingestion (8). Because van Zeyl et al (15) reported no differences
in plasma glucose oxidation with ingestion of MCTs, it is
unlikely that we would have observed glycogen sparing in this
study, as total carbohydrate oxidation rates were similar.
In conclusion, the present study showed that large amounts of
MCTs (85 g) coingested with carbohydrates did not significantly
affect total rates of carbohydrate and fat oxidation and had no
positive effect on performance. When only MCTs were ingested,
performance decreased by 17–18%, probably as a result of gas-
trointestinal distress.
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